Monday, January 26, 2015

Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A unexplored check-up marketed as an option to a mammogram for knocker cancer detection is not an true screening TOOL, US health officials say. With the nipple aspirate test, a teat quiz collects fluid from a woman's nipple. The aqueous is then examined for anomalous and potentially cancerous cells best pro med. The check is advertised as easier, more comfortable and less painful than mammograms.

However, there is no test to support claims that the test can feel breast cancer, said Dr David Lerner, a medical dick at the US Food and Drug Administration and a core imaging specialist orviax. "FDA's relate to is that the nipple aspirate exam is being touted as a standalone tool to screen for and interpret breast cancer as an alternative to mammography," Lerner said in an energy news release.

So "Our cravenness is that women will forgo a mammogram and have this trial instead". Skipping a mammogram could put a woman's constitution and life at risk if breast cancer goes undetected, Lerner warned. He said there is no painstaking prove that the nipple aspirate test, when hand-me-down on its own, is an effective screening tool for tit cancer or any other medical condition.

The test is still being conscious to determine if it might be useful in combination with other methods to hide for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of bust cancer," Lerner said. "Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate evaluation - called the ForeCYTE Breast Health Test - off the bazaar after being warned by the FDA that its claims about the prove were unsubstantiated. The enterprise claimed the proof was "literally a Pap vilification for boob cancer". Pap smears are a universal examine for cervical cancer.

And Women who have had a nipple aspirate try as a form of bosom cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should knock to their tamper with about whether additional tests are needed, the FDA said. One in eight US women will commence heart cancer in her lifetime boxrxlist.com. The plague is the second leading cancer killer of women in the country.

No comments:

Post a Comment